Status:
COMPLETED
The Better Sleep for Supporters With Insomnia Study
Lead Sponsor:
University of Virginia
Conditions:
Family Caregivers
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will identify whether - and if so, how - tailoring would increase adoption of and benefit from an interactive internet intervention for insomnia called SHUTi (Sleep Healthy Using the Intern...
Detailed Description
Insomnia is a significant public health problem with substantial medical, psychological and financial ramifications. About 50-75% of the 3.5 million Americans who provide unpaid medical, practical, an...
Eligibility Criteria
Inclusion
- self-report providing unpaid care (e.g., practical, medical, and/or emotional support) to an adult family member or "family-like" close individual who is either currently undergoing any anti-cancer treatment (e.g., surgery, chemotherapy, radiation, for either curative or palliative intent) or has completed anti-cancer treatment within the past 2 years.
- Insomnia severity index score of 10 or higher
- age 18 and over
- regular access (at least 2/week) and willingness to use a computer and the Internet and check email
- ability to read and speak English
- resident of the US
Exclusion
- irregular sleep schedules that prevent the ability to follow intervention recommendations (i.e., with usual bedtimes outside of 8:00pm to 2:00am or arising time outside of 4:00am to 10:00am)
- current psychological treatment for insomnia
- screen positive for a history of psychotic or bipolar disorder; and current severe depression, high risk of suicide, substance use (alcohol, drug) disorder within the past year
- symptoms suggestive of untreated sleep disorders other than insomnia (e.g., obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder)
- presence of uncontrolled medical condition that is deemed to interfere with the study procedures, or put the study participant at undue risk
- Unstable medication regimen (change to schedule or dosage within past 3 months) for a prescription medication regimen thought to impact sleep.
Key Trial Info
Start Date :
September 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04661306
Start Date
September 30 2020
End Date
January 31 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia
Charlottesville, Virginia, United States, 22903